| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8218016 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 8 Pages |
Abstract
Preliminary results suggest that the strategy of neoadjuvant sandwich treatment using XELOX regimen as induction, concomitant, and consolidation chemotherapy to the conventional radiation is well tolerated. The strategy is highly effective in terms of pCR and major regression, which warrants further investigation.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yuan-Hong MD, Jun-Zhong MD, Xin MD, Jie-Lin MD, Mu-Yan MD, Pei-Qiang MD, Ling-Heng MD, Guo-Chen MD, Jing-Hua MD, Gong MD, Zhi-Zhong MD, Pei-Rong MD,